These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 32145676

  • 21. The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network.
    Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, Liang Y, Zhu F, Zhang Y, Zhang X, Yuan Q, Li Y.
    Oncogene; 2019 May; 38(19):3667-3680. PubMed ID: 30659266
    [Abstract] [Full Text] [Related]

  • 22. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.
    Xu T, Zhang W, Chai L, Liu C, Zhang S, Xu T.
    Oral Dis; 2023 Mar; 29(2):639-648. PubMed ID: 34479400
    [Abstract] [Full Text] [Related]

  • 23. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m6A-YTHDF1-dependent manner.
    Zhang R, Chen P, Wang Y, Zeng Z, Yang H, Li M, Liu X, Yu W, Hou P.
    Int J Biol Sci; 2024 Mar; 20(12):4750-4766. PubMed ID: 39309428
    [Abstract] [Full Text] [Related]

  • 24. Role of METTL3-Dependent N6-Methyladenosine mRNA Modification in the Promotion of Angiogenesis.
    Yao MD, Jiang Q, Ma Y, Liu C, Zhu CY, Sun YN, Shan K, Ge HM, Zhang QY, Zhang HY, Yao J, Li XM, Yan B.
    Mol Ther; 2020 Oct 07; 28(10):2191-2202. PubMed ID: 32755566
    [Abstract] [Full Text] [Related]

  • 25. METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.
    Peng Z, Gong Y, Wang X, He W, Wu L, Zhang L, Xiong L, Huang Y, Su L, Shi P, Cao X, Liu R, Li Y, Xiao H.
    Mol Ther; 2022 Feb 02; 30(2):932-946. PubMed ID: 34547464
    [Abstract] [Full Text] [Related]

  • 26. RNA N6-Methyladenosine (m6A) Methyltransferase-like 3 Facilitates Tumorigenesis and Cisplatin Resistance of Arecoline-Exposed Oral Carcinoma.
    Wang C, Kadigamuwa C, Wu S, Gao Y, Chen W, Gu Y, Wang S, Li X.
    Cells; 2022 Nov 14; 11(22):. PubMed ID: 36429032
    [Abstract] [Full Text] [Related]

  • 27. METTL3-mediated m6A modification of SOX4 regulates osteoblast proliferation and differentiation via YTHDF3 recognition.
    Feng ZW, Peng B, Wang SH, Zhao DC, Wang YB, Yang A, Zhan HW, Sheng XY, Xu LH, Ren XJ, Yang F, Geng B, Xia YY.
    Cell Signal; 2024 Mar 14; 115():111038. PubMed ID: 38195035
    [Abstract] [Full Text] [Related]

  • 28. Mettl3 regulates hypertrophic differentiation of chondrocytes through modulating Dmp1 mRNA via Ythdf1-mediated m6A modification.
    He Y, Wang W, Luo P, Wang Y, He Z, Dong W, Jia M, Yu X, Yang B, Wang J.
    Bone; 2022 Nov 14; 164():116522. PubMed ID: 35981698
    [Abstract] [Full Text] [Related]

  • 29. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m6A/c-Myc-dependent aerobic glycolysis.
    Zhang Q, Zhang Y, Chen H, Sun LN, Zhang B, Yue DS, Wang CL, Zhang ZF.
    Cell Cycle; 2022 Dec 14; 21(24):2602-2614. PubMed ID: 35972892
    [Abstract] [Full Text] [Related]

  • 30. COL1A1, mediated by m6A methylation of METTL3, facilitates oral squamous cell carcinoma cell growth and metastasis.
    Lv R, Yao Y, Dong J, Chen Q.
    Odontology; 2024 Jun 20. PubMed ID: 38900231
    [Abstract] [Full Text] [Related]

  • 31. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
    Zhou Y, Yin Z, Hou B, Yu M, Chen R, Jin H, Jian Z.
    Cancer Manag Res; 2019 Jun 20; 11():3921-3931. PubMed ID: 31118805
    [Abstract] [Full Text] [Related]

  • 32. New insights on the interaction between m6A modification and non-coding RNA in cervical squamous cell carcinoma.
    Shen G, Li F, Wang Y, Huang Y, Aizezi G, Yuan J, Ma C, Lin C.
    World J Surg Oncol; 2023 Jan 30; 21(1):25. PubMed ID: 36710350
    [Abstract] [Full Text] [Related]

  • 33. N6-methyladenosine (m6A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner.
    Shen H, Xie K, Li M, Yang Q, Wang X.
    Cell Death Discov; 2022 Jul 15; 8(1):322. PubMed ID: 35840562
    [Abstract] [Full Text] [Related]

  • 34. Dynamic m6A mRNA methylation reveals the role of METTL3-m6A-CDCP1 signaling axis in chemical carcinogenesis.
    Yang F, Jin H, Que B, Chao Y, Zhang H, Ying X, Zhou Z, Yuan Z, Su J, Wu B, Zhang W, Qi D, Chen D, Min W, Lin S, Ji W.
    Oncogene; 2019 Jun 15; 38(24):4755-4772. PubMed ID: 30796352
    [Abstract] [Full Text] [Related]

  • 35. METTL3 Promotes OSCC Progression by Down-Regulating WEE1 in a m6A-YTHDF2-Dependent Manner.
    Su Y, Hu Y, Qu B, Lei R, Guo G.
    Mol Biotechnol; 2024 May 14. PubMed ID: 38744787
    [Abstract] [Full Text] [Related]

  • 36. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO, Wong CM.
    Hepatology; 2018 Jun 14; 67(6):2254-2270. PubMed ID: 29171881
    [Abstract] [Full Text] [Related]

  • 37. N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer.
    Jin H, Ying X, Que B, Wang X, Chao Y, Zhang H, Yuan Z, Qi D, Lin S, Min W, Yang M, Ji W.
    EBioMedicine; 2019 Sep 14; 47():195-207. PubMed ID: 31409574
    [Abstract] [Full Text] [Related]

  • 38. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
    Zhou L, Yang C, Zhang N, Zhang X, Zhao T, Yu J.
    Biomed Pharmacother; 2020 May 14; 125():109964. PubMed ID: 32044716
    [Abstract] [Full Text] [Related]

  • 39. METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.
    Han H, Yang C, Zhang S, Cheng M, Guo S, Zhu Y, Ma J, Liang Y, Wang L, Zheng S, Wang Z, Chen D, Jiang YZ, Lin S.
    Mol Ther Nucleic Acids; 2021 Dec 03; 26():333-346. PubMed ID: 34513313
    [Abstract] [Full Text] [Related]

  • 40. METTL3/YTHDF1 m6A axis promotes tumorigenesis by enhancing DDR2 expression in ovarian cancer.
    Zhi D, Zhou K, Liu S, Yu W, Dong M, Yan C.
    Pathol Res Pract; 2024 Jan 03; 253():155047. PubMed ID: 38154356
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.